Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-17-003553
Filing Date
2017-09-11
Accepted
2017-09-11 08:00:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 MATRIX CAPITAL MANAGEMENT COMPANY LP p17-1829sc13g.htm SC 13G 63991
  Complete submission text file 0000902664-17-003553.txt   65813
Mailing Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451
Business Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 781-522-4948
Matrix Capital Management Company, LP (Filed by) CIK: 0001410830 (see all company filings)

EIN.: 043475951 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88833 | Film No.: 171077973
SIC: 2836 Biological Products, (No Diagnostic Substances)